Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTRC | Q99895 | 1/20 | 0.51 |
| ▸ | ENPP3 | O14638 | 2/20 | 0.49 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.49 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.46 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.44 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.44 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.44 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.44 |
| ▸ | RAC1 | P63000 | 1/20 | 0.43 |
| ▸ | XDH | P47989 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18731959 | 0.95 | CTRC (0.57) | CTRCENPP3CYP1A1CYP1B1CYP1A2 | |
| SCHEMBL4546880 | 0.90 | ENPP3 (0.57) | ENPP3MEN1KMT2AXDH | |
| SCHEMBL4546995 | 0.88 | MEN1 (0.54) | ENPP3MEN1KMT2ATDP1CYP19A1 | |
| SCHEMBL4546977 | 0.88 | MEN1 (0.54) | ENPP3MEN1KMT2ATDP1CYP19A1 | |
| SCHEMBL4546994 | 0.88 | MEN1 (0.54) | ENPP3MEN1KMT2ATDP1CYP19A1 | |
| SCHEMBL4546983 | 0.88 | ENPP3 (0.56) | ENPP3MEN1KMT2AXDH | |
| SCHEMBL4546976 | 0.88 | MEN1 (0.57) | ENPP3MEN1KMT2ATDP1CYP19A1 | |
| SCHEMBL14425870 | 0.88 | CYP1A1 (0.56) | CTRCCYP1A1CYP1B1CYP1A2HSD17B1 | |
| SCHEMBL4546876 | 0.86 | MEN1 (0.60) | ENPP3MEN1KMT2ATDP1CYP19A1 | |
| SCHEMBL22058447 | 0.86 | CYP1A1 (0.59) | CTRCCYP1A1CYP1B1CYP1A2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8877355-B2 | Monoamine compound, charge-transporting material, and organic electroluminescent device | MITSUBISHI CHEMICAL CORPORATION (JP) | 2014-11-04 | — | — | US | disclosed |
| US-20130214263-A1 | MONOAMINE COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT DEVICE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2013-08-22 | — | — | US | disclosed |
| US-8427046-B2 | Monoamine compound, charge-transporting material, and organic electroluminescent device | MITSUBISHI CHEMICAL CORPORATION (JP) | 2013-04-23 | — | — | US | disclosed |
| US-8178215-B2 | Organic compound containing at least two carbazolyl-substituted phenyl structures; charge-transporting material and organic el element containing the compound | PIONEER CORPORATION (JP) | 2012-05-15 | — | — | US | disclosed |
| US-20090236973-A1 | ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT | PIONEER CORPORATION (JO) | 2009-09-24 | — | — | US | disclosed |
| US-20090230846-A1 | MONOAMINE COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT DEVICE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2009-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090236973-A1 | ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT | SLCO4C1, SLCO2A1, SLCO2B1 | CTRC 1692/4885ENPP3 3213/4885CYP1A1 446/4885 |
| US-20090230846-A1 | MONOAMINE COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT DEVICE | SLC7A5, SLC18A1, MAOA | CTRC 1933/4885ENPP3 3276/4885CYP1A1 261/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.